Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function

Clinical Transplantation

Volumn 10, Issue 6 II, 1996, Pages 639-645

  Leech, Stephen H ^a,b   Mather, Paul J ^a   Elsen, Howard J ^a   Pina, Lleana L ^a   Margulies, Kenneth B ^a   Bove, Alfred A ^a   Jeevanandam, Valluvan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Graft rejection; Heart transplantation; HLA antibodies; HLA DQ

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HLA DQ ANTIGEN; LYMPHOCYTE ANTIBODY;

ADULT; ARTICLE; DETERIORATION; FEMALE; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTILYMPHOCYTE SERUM; FATAL OUTCOME; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; REOPERATION; VENTRICULAR DYSFUNCTION;

EID: 0030449645     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. FENOGLIO J, Ho E, REED E, et al. Anti-HLA antibodies and heart allograft survival Transpl Proc 1989: 21: 807.
2. HAMMOND EH, YOWELL RL, NUNODA S, et al. Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications J Heart Transpl 1989: 8: 430
3. FESTENSTEIN H, BANNER N, SMITH J, et al. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine. Transpl Proc 1989: 21: 797.
4. ZERBE TR, ARENA VC, KORMOS RL, GRIFFITH BP, HARDESTY RL, DUQUESNOY RJ. Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation. Transplant 1991: 52: 485.
5. LAVEE J, KORMOS RL, DUQUESNOY RJ, et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transpl 1991: 10: 921.
6. NELSON K, ALLEN MD, YOUNGS D, AZIZ S, MONTERO R, FISHBEIN D, SLACHMAN F. Significance of B cell crossmatches in cardiac transplantation. Human Immunol. 1992. 34 (Suppl. 1): 71.
7. JOYSEY VC. Tissue typing, heart and heart-lung transplantation. Brit Biomed Sci 1993: 50: 272.
8. KERMAN RH, KIMBALL P, SCHEINEN S, et al. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients. Transplantation 1994: 57: 884.
9. LOH E, BERGIN JD, COUPER GS, MUDGE GH. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transpl 1994: 13: 194.
10. McCLOSKEY D, FESTENSTEIN H. BANNER N. et al. The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival. Transpl Proc 1989: 21: 804.
11. HESS ML, HASTILLO A, MOHANAKUMAR T, et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B cell antibodies and hyperlipidemia. Circulation 1983: 68(3 Pt 2): 1194
12. PETROSSIAN GA, NICHOLS AB, MARBOE CC, et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 1989: 80 (suppl III): 122.
13. ROSE EA, SMITH CR, PETROSSIAN GA, BARR ML, REEMTSMA K. Humoral immune responses after cardiac transplantation: correlation with fetal rejection and graft atherosclerosis. Surgery 1989: 203.
14. SUCIU-FOCA N. REED E, MARBOE C. et al. The role of anti-HLA antibodies in heart transplantation. Transpl 1991: 51. 716.
15. CHERRY R, NIELSEN H, REED E, REEMTSMA K. SUCIU-FOCA N. MARBOE CC. Vascular (humoral) rejection in human cardiac allograft biopsies: Relation to circulating anti-HLA antibodies. J Heart Lung Transpl 1992: 11: 24.
16. BARR ML. COHEN DJ, BENVENISTY AI, et al. Effect of antiHLA antibodies on the long-term survival of heart and kidney allografts. Transpl Proc 1993: 25: 262.
17. ZUCKER MJ, FUZESI L. RIBNER HS, PANCOSKA P. Biventricular dysfunction after heart transplantation: reversal with extracorporeal immunoadsorption. J Heart Lung Transpl 1995: 14: 228.
18. NIKAEIN A, ALIVIZATOS PA, MONAHAN K, STONE MJ. The role of anti-class II HLA antibodies in heart transplantation. Transplantation 1995: 59: 439.
19. SMITH JD, MORGAN AJ, BRAVERY C, ROSE ML, SACHS JA. YACOUB MH. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation. Transpl Proc 1991: 23: 1133.
20. RAY JG, HARE DB, PEDERSON PD, MULLALY DI. NIAID Manual of Tissue Typing Techniques. 1976-1977. Bethesda: National Institutes of Health, 1976.
21. RODEY GG, ed. HLA Beyond Tears. Chapt. 4. Atlanta: De-Novo. Inc. 1992: p. 53.
22. HILLER MC, SHULMAN NR. Characterization of leukocyte and platelet antigens shared by non-human primates and man Ann NY Acad Sci 1969: 162: 429.
23. STEINBERG AG. COOK CE. The distribution of human immunoglobulin allotypes. Oxford: Oxford University Press. 1981.
24. SVEJGARD A. JERSILD C, STAUB-NIELSON L, BODMER WF HL-A antigens and disease: statistical and genetical considerations. Tissue Antigens 1974: 4: 95.
25. BILLINGHAM ME, CARY NR, HAMMOND ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transpl 1990: 9: 587.
26. HAMMOND EH. YOWELL RL. NUNODA S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transpl 1989: 8: 430.
27. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, et al. Kidney Int 1993: 44: 411.
28. TSUJI K. AIZAMA M. SASAZUKI T. eds. HLA 1991. Proceedings of the 11th International Histocompatibility Workshop. Oxford: Oxford University Press, 1992.
29. MONOS DS, FRANK TS. SENIOR MB. et al. Delineation of false-positive HIV antibody response in patients with renal failure and history of multiple transfusions. Transfusion 1989: 29: 119.
30. MOHANAKUMAR T, RHODES C, MENDEZ-PICON G, GOLDMAN M, MONCURE C, LEE H. Renal allograft rejection associated with presensitization to HLA-DR antigens. Transplantation 1981: 31: 93.
31. AHERN AT, ARTRUC SB, DELLAPELLE P, et al. Hyperacute rejection of HLA-AB-identical renal alloarafts associated with B lymphocyte and endothelial reactive antibodies. Transplantation 1982; 33: 103.
32. GORDON C. SAUNDERS PH, BANOWSKY LH, JOHNSON A. Hyperacute rejection of a living-related donor kidney associated with pregraft monocytes and B lymphocyte reactive antibodies. Human Immunol 1985: 14: 151.
33. TAYLOR CJ, CHAPMAN JR. FUGGLE SV, TING A, MORRIS PJ. A positive B-cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft. Tissue Antigens 1987: 30: 104.
34. SCORNIK JC, LEFOR WM, CICCIARELLI JC, et al. Hyperacute acute kidney graft rejection due to antibodies against B cells. Transplantation 1992: 54: 61.